cGAS-STING signalling regulates microglial chemotaxis in genome instability
Nucleic Acids Research · 09.02.2024 · 52 (3) · 1188-1206
DOI: 10.1093/nar/gkad1184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 12.12.2023. Verfasst von Emily J Talbot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Microglia, Neurodegenerative Diseases, Signal Transduction. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Royal Society Sir Henry Dale Fellowship, Wellcome-Beit Prize.
Abstract (Originalsprache)
Defective DNA damage signalling and repair is a hallmark of age-related and genetic neurodegenerative disease. One mechanism implicated in disease progression is DNA damage-driven neuroinflammation, which is largely mediated by tissue-resident immune cells, microglia. Here, we utilise human microglia-like cell models of persistent DNA damage and ATM kinase deficiency to investigate how genome instability shapes microglial function. We demonstrate that upon DNA damage the cytosolic DNA sensing cGAS-STING axis drives chronic inflammation and a robust chemokine response, exemplified by production of CCL5 and CXCL10. Transcriptomic analyses revealed that cell migratory pathways were highly enriched upon IFN-β treatment of human iPSC-derived microglia, indicating that the chemokine response to DNA damage mirrors type I interferon signalling. Furthermore, we find that STING deletion leads to a defect in microglial chemotaxis under basal conditions and upon ATM kinase loss. Overall, this work provides mechanistic insights into cGAS-STING-dependent neuroinflammatory mechanisms and consequences of genome instability in the central nervous system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Cambridge, Cambridge, UK.
- Neuroscience, R&D BioPharmaceuticals, AstraZeneca, Cambridge, UK.
- Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Gothenburg, Sweden.
- Department of Data Sciences & Quantitative Biology, AstraZeneca, Cambridge, UK.
ORCID-Profile: Svetlana V Khoronenkova
Förderung
- Wellcome Trust
- Royal Society Sir Henry Dale Fellowship
- Wellcome-Beit Prize
- Royal Society
- University of Cambridge
- AstraZeneca PhD studentship
- Ataxia Telangiectasia Society
Zitieren
APA
Talbot, E. J., Joshi, L., Thornton, P., Dezfouli, M., Tsafou, K., Perkinton, M., & Khoronenkova, S. V. (2024). cGAS-STING signalling regulates microglial chemotaxis in genome instability. Nucleic Acids Research, 52(3), 1188-1206. https://doi.org/10.1093/nar/gkad1184
Vancouver
Talbot EJ, Joshi L, Thornton P, Dezfouli M, Tsafou K, Perkinton M, et al. cGAS-STING signalling regulates microglial chemotaxis in genome instability. Nucleic Acids Research. 2024;52(3):1188-1206. doi:10.1093/nar/gkad1184
BibTeX
@article{Talbot2024,
author = {Talbot, Emily J and Joshi, Lisha and Thornton, Peter and Dezfouli, Mahya and Tsafou, Kalliopi and Perkinton, Michael and Khoronenkova, Svetlana V},
title = {cGAS-STING signalling regulates microglial chemotaxis in genome instability},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {3},
pages = {1188--1206},
doi = {10.1093/nar/gkad1184}
}
EUVIMED